About the Journal Watch Infectious Diseases Editorial Board
Larry M. Baddour, MD, Editor-in-Chief
Larry M. Baddour, MD, FIDSA, FAHA, is the HH Sheikh Khalifa Bin Zayed Al-Nahyan Professor of Infectious Diseases Honoring Walter R. Wilson, MD, and Chair, Division of Infectious Diseases at Mayo Clinic College of Medicine, Rochester, Minnesota. He has career-long interests in skin and soft-tissue infections and cardiovascular infections. He provided the initial clinical description of postvenectomy cellulitis among coronary artery bypass patients, in 1982. He also provided an early description of breast cellulitis complicating breast conservation therapy. He has analyzed risk factors for this complication and for lower-extremity cellulitis. Dr. Baddour’s laboratory and clinical work on cardiovascular infections has yielded more than 100 publications. A member of the American Heart Association’s Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee since 1999, he has first-authored three Scientific Statements for the group and now serves as Chairman. Dr. Baddour began editing and writing for Journal Watch Infectious Diseases in 2007.
Richard T. Ellison III, MD, Deputy Editor
Richard T. Ellison III, MD, is Professor of Medicine, Molecular Genetics and Microbiology in the Division of Infectious Diseases and Immunology at the University of Massachusetts Medical School, Worcester. His research interests include nosocomial infections, HIV disease, infection control, and control and treatment of infections caused by antibiotic-resistant bacteria. He has pursued basic investigations into innate host defenses against bacterial pathogens and into novel antimicrobial agents active against antibiotic-resistant bacteria. A hospital epidemiologist, Dr. Ellison has focused his investigations on treating hospital-acquired infections and HIV disease. He is a past president of the Massachusetts Infectious Diseases Society. He has written for Journal Watch Infectious Diseases and served as Deputy Editor since the publication was launched in 1998.
Neil R. Blacklow, MD, Founding Editor
Neil R. Blacklow, MD, is Professor and Chairman Emeritus of the Department of Medicine, Molecular Genetics and Microbiology at the University of Massachusetts Medical School, Worcester, and founding Director of the Division of Infectious Diseases at that institution. In addition, he is a Lecturer on Medicine at Harvard Medical School. He has conducted extensive research on the etiology, pathogenesis, and diagnosis of viral gastroenteritis, most notably illness involving norovirus, rotavirus, and astrovirus. The co-discoverer of adenovirus-associated viruses, he showed that these viruses infect humans. He also has directed an AIDS Clinical Trials Group center. Dr. Blacklow has been writing for Journal Watch Infectious Diseases since its inception in 1998 and served as editor-in-chief for 10 years.
Neil M. Ampel, MD, Associate Editor
Neil M. Ampel, MD, is Professor of Medicine and Public Health at the University of Arizona College of Medicine and Staff Physician at the Arizona Veterans Affairs Health Care System in Tucson. His clinical interests include HIV infection and fungal infections, particularly coccidioidomycosis, and his research focuses on the cellular immune response in coccidioidomycosis. Dr. Ampel is a member of the NIH/CDC/IDSA Working Group for Therapy of Opportunistic Infections and the American Thoracic Society’s Committee on the Treatment of Fungal Diseases Complicating AIDS. He is a former president of the Veterans Administration Society for Practitioners of Infectious Diseases. Dr. Ampel has been writing for Journal Watch Infectious Diseases since 2002.
Robert S. Baltimore, MD, Associate Editor
Robert S. Baltimore, MD, is Professor of Pediatrics and Epidemiology at Yale University School of Medicine and Associate Hospital Epidemiologist for Pediatrics, Yale–New Haven Hospital, New Haven. He is Director of the Pediatric Tuberculosis Clinic and Co-Director of the Training Program in Pediatric Infectious Diseases at Yale–New Haven Children’s Hospital. Dr. Baltimore’s research has focused on group B streptococcus, Pseudomonas aeruginosa, neonatal infections, and nosocomial infections. He is a member of the Committee on Infectious Diseases of the American Academy of Pediatrics (the “Red Book” Committee) and a liaison member of the American Heart Association’s Committee on Rheumatic Fever, Infective Endocarditis, and Kawasaki Disease. Dr. Baltimore has been writing for Journal Watch Infectious Diseases since the publication was launched in 1998.
Stephen G. Baum, MD, Associate Editor
Stephen G. Baum, MD, is Senior Associate Dean for Students and Professor of Medicine and of Microbiology and Immunology at the Albert Einstein College of Medicine, Bronx, New York. Previously, he was Chairman of the Department of Medicine at Beth Israel Medical Center in New York. He has conducted extensive research on DNA tumor viruses (adenovirus and SV40). A former president of the New York Society for Infectious Diseases, Dr. Baum has written chapters on adenovirus, mumps, aseptic meningitis, mycoplasma, and viral pneumonia for several textbooks. He currently serves on the New York City Department of Health and Mental Hygiene’s Hospital Bioterrorism Advisory Subcommittee of the Weapons of Mass Destruction Advisory Group. Dr. Baum has been writing for Journal Watch Infectious Diseases since the publication was launched in 1998.
Rajesh T. Gandhi, MD, Associate Editor
Rajesh T. Gandhi, MD, is Associate Professor of Medicine at Harvard Medical School and Director of HIV Clinical Services and Education at Massachusetts General Hospital. He is the site leader of the Massachusetts General Hospital AIDS Clinical Trials Site in the Harvard/Boston Medical Center/Miriam AIDS Clinical Trials Unit. He is also the Director of the Harvard University Center for AIDS Research (CFAR) Clinical Core. He is the editor of Partners ID Images, an educational infectious diseases website, and organizer of the HIV Online Provider Education (HOPE) program, which is an Internet-based educational conference series for physicians caring for HIV-infected patients in resource-limited settings. His research interests are in clinical trials of immune-based therapies for HIV and in HIV/viral hepatitis coinfection. He has been writing for Journal Watch since 2005.
Thomas Glück, MD, Associate Editor
Thomas Glück, MD, is Professor of Medicine at the University of Regensburg, Chief, Department of Internal Medicine, District Hospital Trostberg, and Chief, Infectious Diseases Consulting Service, District Hospitals, Traunstein and Trostberg, Bavaria, Germany. A member of the Bavarian infectious diseases specialty board, he received his specialty training in the U.S. His research interests include clinical sepsis, pathogenesis of sepsis, and infections in immunocompromised patients. Dr. Glück has been writing for Journal Watch Infectious Diseases since 2004.
Mary E. Wilson, MD, Associate Editor
Mary E. Wilson, MD, is Associate Clinical Professor of Medicine at Harvard Medical School and Associate Professor, Department of Global Health and Population at the Harvard School of Public Health. Her academic interests include tuberculosis, ecology of infections, emergence of new infections, determinants of disease distribution, travel medicine, and vaccines. She has served on the Advisory Committee for Immunization Practices of the CDC and the Academic Advisory Committee for the National Institute of Public Health in Mexico. Dr. Wilson has been writing for Journal Watch Infectious Diseases since the publication was launched in 1998.
Daniel J. Diekema, MD, MS, Contributing Editor
Daniel J. Diekema, MD, D(ABMM), is Professor in the Departments of Internal Medicine and Pathology at the University of Iowa Roy J. and Lucille A. Carver College of Medicine. He is Director of the Division of Infectious Diseases and serves as Associate Hospital Epidemiologist and Associate Director of the Clinical Microbiology Laboratory at the University of Iowa Hospitals and Clinics. Dr. Diekema’s academic interests are in hospital epidemiology and clinical mycology. His current research interests include the control of antimicrobial-resistant bacterial pathogens (primarily MRSA and VRE), the epidemiology of invasive fungal infections in the healthcare setting, and the epidemiology of antifungal drug resistance among Candida spp. He has been writing for Journal Watch Infectious Diseases since 2006.
Lynn L. Estes, PharmD, Contributing Editor
Dr. Estes is Assistant Professor of Medicine at Mayo Clinic College of Medicine, and Infectious Disease Pharmacy Specialist at Mayo Clinic, Rochester, Minnesota. She has been involved with development and enhancement of a computer-based antimicrobial monitoring program since 1992. Her interests include antimicrobial stewardship, antifungal therapies, formulary management, antimicrobial pharmacokinetics/dynamics, appropriate dosing and monitoring of antimicrobials, HIV pharmacotherapy, teaching, and clinical research in infectious diseases. Dr. Estes began writing for Journal Watch Infectious Diseases in 2008.
EDITORS WHO HAVE LEFT THE BOARD SINCE JANUARY 2007
Bradley E. Britigan, MD, Associate Editor 1998–2008
Bradley E. Britigan, MD, is Professor and Chairman of the Department of Internal Medicine at the University of Cincinnati College of Medicine and VA Medical Center in Cincinnati. Before that, he served as Director of the Division of Infectious Diseases at the University of Iowa for 10 years. Dr. Britigan’s research interests focus on oxygen and iron metabolism of phagocytic cells and pathogenic organisms. His current research explores the nature of oxygen-centered free radicals essential to the microbicidal function of phagocytes, as well as the possible role of toxic free radicals in Pseudomonas aeruginosa–induced tissue injury. He is past president of the American Federation for Medical Research. Dr. Britigan wrote for Journal Watch Infectious Diseases from 1998 to 2008.